---
title: "RBC Capital Remains a Buy on Praxis Precision Medicines (PRAX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292368869.md"
description: "RBC Capital analyst Leonid Timashev maintained a Buy rating on Praxis Precision Medicines (PRAX) with a $449 price target. This follows a June 30 report where Guggenheim also issued a Buy, while Wells Fargo assigned a Hold rating to the stock."
datetime: "2026-07-11T01:47:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292368869.md)
  - [en](https://longbridge.com/en/news/292368869.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292368869.md)
---

# RBC Capital Remains a Buy on Praxis Precision Medicines (PRAX)

RBC Capital analyst Leonid Timashev maintained a Buy rating on Praxis Precision Medicines yesterday and set a price target of $449.00.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Timashev is a 5-star analyst with an average return of 27.9% and a 62.34% success rate. Timashev covers the Healthcare sector, focusing on stocks such as Insmed, Revolution Medicines, and ADC Therapeutics.

In addition to RBC Capital, Praxis Precision Medicines also received a Buy from Guggenheim’s Yatin Suneja in a report issued on June 30. However, on the same day, Wells Fargo assigned a Hold rating to Praxis Precision Medicines (NASDAQ: PRAX).

### Related Stocks

- [PRAX.US](https://longbridge.com/en/quote/PRAX.US.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [INSM.US](https://longbridge.com/en/quote/INSM.US.md)
- [RVMD.US](https://longbridge.com/en/quote/RVMD.US.md)
- [ADCT.US](https://longbridge.com/en/quote/ADCT.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [RVMDW.US](https://longbridge.com/en/quote/RVMDW.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)

## Related News & Research

- [Praxis Precision Medicines (PRAX) Wins FDA Breakthrough Tag As CNS Pipeline Advances](https://longbridge.com/en/news/295313402.md)
- [Glenmede Trust Co. NA Sells 2,878 Shares of Praxis Precision Medicines, Inc. $PRAX](https://longbridge.com/en/news/295207096.md)
- [Praxis Q2 2026 results: $1.4 billion liquidity supports runway into 2028](https://longbridge.com/en/news/295110125.md)
- [Praxis Precision Q2 net loss widens on higher expenses](https://longbridge.com/en/news/295106132.md)
- [Praxis Precision Medicines posts investor deck highlighting late-stage CNS pipeline, upcoming PDUFA dates](https://longbridge.com/en/news/295108601.md)